Healthcare technology company Zenosense (OTC: ZENO) is well positioned to capitalize on the projected growth in the global point-of-care (“POC”) diagnostics market, forecast to grow at a CAGR of 10 percent, from $23.71 billion in 2017 to $38.13 billion in 2022 according to a recent Research and Markets report (http://nnw.fm/o0fNq), through the development and commercialization of its MIDS Cardiac device. An article discussing the company reads: “MIDS’ key differentiator is its unique ability to detect and measure these assay beads by their total aggregated nano-magnetic signal, rather than conventional optical detection. Initial testing has demonstrated that this novel approach should enable MML to develop a highly sensitive, accurate, miniaturized device to support high-sensitivity cardiac biomarker testing. Such a POC device could be used in the emergency room, a doctor’s office, the bedside and by paramedics in emergency situations, such as in an ambulance.”
To view the full article, visit http://nnw.fm/uv74S
About Zenosense, Inc.
Zenosense Inc.’s primary focus, through its joint venture ownership in MIDS Medical Ltd., is the development of a cost-effective, hand-held Point of Care rapid cardiac diagnostic device, MIDS Cardiac™, and is also the holder of an exclusive global license agreement to develop and market effective medical devices for use in hospitals and primary healthcare settings targeting the early detection of both deadly bacteria and certain cancers in the exhaled breath of patients. For more information, visit the company’s website at www.ZenoSense.com.
More from NetworkNewsBreaks
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]